CN1101202C - Compound Chinese medicine preparation for treating hyperosteogeny - Google Patents
Compound Chinese medicine preparation for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1101202C CN1101202C CN 00110131 CN00110131A CN1101202C CN 1101202 C CN1101202 C CN 1101202C CN 00110131 CN00110131 CN 00110131 CN 00110131 A CN00110131 A CN 00110131A CN 1101202 C CN1101202 C CN 1101202C
- Authority
- CN
- China
- Prior art keywords
- present
- herba
- radix
- chinese medicine
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 150000001875 compounds Chemical class 0.000 title claims abstract description 5
- 239000003814 drug Substances 0.000 title claims description 10
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims description 19
- 241000005787 Cistanche Species 0.000 claims description 10
- 241000903946 Clematidis Species 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 8
- 208000002193 Pain Diseases 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 11
- 241000736246 Pyrola Species 0.000 abstract description 7
- 210000000988 bone and bone Anatomy 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 206010030113 Oedema Diseases 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 230000008520 organization Effects 0.000 abstract description 3
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 2
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 2
- 206010020718 hyperplasia Diseases 0.000 abstract description 2
- 201000008482 osteoarthritis Diseases 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 208000005801 spondylosis Diseases 0.000 abstract description 2
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 201000002661 Spondylitis Diseases 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000027744 congestion Diseases 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 8
- 239000002994 raw material Substances 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 108010048734 sclerotin Proteins 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000146 antalgic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 206010048873 Traumatic arthritis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a compound traditional Chinese preparation for hyperosteogeny, which is suitable for treating cervical vertebra inflammation, cervical spondylosis, talalgia, kaschin beck diseases andtraumatic arthritis. The present invention comprises the components of the proportion by weight in a formula: 10 to 30% of prepared rehmannia rhizome, 5 to 20% of Chinese pyrola herb, 10 to 20% of broomrape, 4 to 20% of drynaria, 10 to 15% of epimedium, 10 to 30% of spatholobus stem, 5 to 15% of radish seed, 3 to 10% of rhizoma corydalis, 4.5 to 9% of cyathula root, 5 to 10% of clematis root and 0.3 to 0.6% of grilling nux vomica. The present invention not only can treat local organization congestion, edema and inflammation because of hyperplasia, and eliminate pain, but also can make bones obtain the sufficient nutrition and repair of essence and blood. Besides, the present invention has the advantages of good curative effect and high curative rate.
Description
The present invention relates to a kind of Chinese medicine preparation, more particularly relate to a kind of compound recipe hyperosteogeny Chinese medicine preparation, be suitable for treating ankylosing spondylitis, cervical spondylosis, talalgia, Kaschin-Beck disease and traumatic arthritis.
Hyperosteogeny belongs to motherland's medical science arthralgia, and clinical symptoms shows as lumbago more, gonalgia, talalgia.Its cause of disease and pathogeny many by Liver and kidney be foot, essence and blood loss or chronic strain, be affected by the cold, damp and hot, caused by energy stagnation and blood stasis, cause the articular cartilage face degeneration, the subcartilaginous osseous lamella reactive hyperplasia causes the joint a series of symptom characteristics such as pain, distortion, movable function is limited to occur.At present to the treatment of hyperosteogeny adopt usually acupuncture, massage, fumigation and wash method hot compress and in, the western drug therapy, but, these therapies can only alleviate and alleviate the pain at hypertrophy position, all there is not the development that specific medicament can stop the state of an illness, and the Western medicine toxic and side effects is big, adopt operative therapy though also have, particularly those serious pain and dysfunction influence routine work and live and reach with the obvious unusual person of mechanical performance, but how not remarkable curative effect is, and the probability of accident in the art and postoperative generation complication is bigger, has brought inconvenience for the treatment work of hyperosteogeny.
The purpose of this invention is to provide a kind of hyperosteogeny Chinese medicine preparation, it can not only dredge the meridian passage, strengthening the tendons and bones, treatment hypertrophy cause local organization hyperemia, edema, inflammation, eliminate pain, and also the sclerotin of just regression obtains fully moistening of essence and blood and supports and repair, therapeutic effect is good, the cure rate height.
The object of the present invention is achieved like this, it is characterized in that its prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 10-30 Herba Pyrolae 5-20
Herba Cistanches 10-20 Rhizoma Drynariae 4-20
Herba Epimedii 10-15 Caulis Spatholobi 10-30
Semen Raphani 5-15 Rhizoma Corydalis 3-10
Radix Cyathulae 4.5-9 Radix Clematidis 5-10
Semen Strychni (processed) 0.3-0.6
In above-mentioned prescription, wherein Radix Rehmanniae Preparata contains retinoid material and aminoacid, the treatment that enrich blood, the kidney invigorating, benefit are smart, is used for deficiency of the liver and kindey, soreness of waist and knee joint; Herba Pyrolae can be dispeled the wind, dehumidifying, invigorating the liver and kidney, bone and muscle strengthening, and stronger bacteriostasis is arranged; But the Herba Cistanches reinforcing the kidney and supporting YANG, can treat the chills and pain of the waist and kness that insufficiency of kidney-YANG causes; Herba Epimedii has kidney-replenishing, wind-damp dispelling, controls the easypro disease of muscles and bones contracture; But Caulis Spatholobi Shujin, active can be treated soreness of waist and knee joint, rheumatic arthralgia; Rhizoma Corydalis contains 20 kinds of alkaloids, has the promoting blood circulation and stopping pain circulation of qi promoting, can control the many pain diseases in joint, and obvious analgesic activity is arranged, and is promoting blood circulation and stopping pain good medicine; The detoxifcation of Semen Raphani anti-inflammatory and antalgic has obvious inhibitory action to various pathogenic bacterias, virus; Radix Cyathulae can be invigorated blood circulation, blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, anti-inflammatory and antalgic, has treatment soreness of waist and knee joint, joint stuffiness effect; But Radix Clematidis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain; Contain alkaloid, fatty oil in the Semen Strychni (processed) all there is excitation in the refreshing smart system of whole maincenter.Sclerotin is given birth to deficiency in both YIN and YANG or the cold-damp that belong to kidney more and is blocked meridians and the deficiency of kidney-QI that arrives, select for use Radix Rehmanniae Preparata, Herba Cistanches to mend essence and fill marrow in order to nourishing the blood and yin, supporing yang spermatogenesis, the Herba Epimedii kidney invigorating and YANG supporting, assistant is with Rhizoma Drynariae, Herba Pyrolae, Caulis Spatholobi, Radix Clematidis the kidney invigorating, enrich blood double blood circulation promoting and blood stasis dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, wind-expelling pain-stopping.Rhizoma Corydalis is used to control limbs pain due to the coagulation of QI-blood, Semen Raphani digestion-promoting spleen-invigorating eliminate indigestion, and greasy now for preventing medicine, eliminating evil just the wound to reach the hold concurrently purpose of smelting of specimen.
Advantage of the present invention is that prescription is many, dosage light, does not have toxic action, it can not only can dredge the meridian passage, strengthening the tendons and bones, treatment hypertrophy cause local organization hyperemia, edema, inflammation, eliminate pain, and the sclerotin that can make regression obtains the foster and reparation of fully moistening of essence and blood, therapeutic effect is good, cure rate height, effective percentage reach more than 90%, relieving rate reaches 70%, cure rate reaches about 50%.
Provide specific embodiments of the invention below.
Embodiment 1
Prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 15 Herba Pyrolaes 10
Herba Cistanches 10 Rhizoma Drynariae 10
Herba Epimedii 10 Caulis Spatholobis 10
Semen Raphani 5 Rhizoma Corydalis 5
Radix Cyathulae 8 Radix Clematidis 7
Semen Strychni (processed) 0.5
After said components taken by weighing by weight, the closeer routinely ball production technology of raw material is made close ball.
Embodiment 2
Prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 20 Herba Pyrolaes 20
Herba Cistanches 20 Rhizoma Drynariae 4
Herba Epimedii 13 Caulis Spatholobis 25
Semen Raphani 10 Rhizoma Corydalis 3
Radix Cyathulae 4.5 Radix Clematidis 5
Semen Strychni (processed) 0.4
After said components taken by weighing by weight, again with raw material routinely the powder production technology make powder.
Embodiment 3
Prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 15 Herba Pyrolaes 5
Herba Cistanches 18 Rhizoma Drynariae 8
Herba Epimedii 15 Caulis Spatholobis 15
Semen Raphani 15 Rhizoma Corydalis 10
Radix Cyathulae 5 Radix Clematidis 9
Semen Strychni (processed) 0.6
After said components taken by weighing by weight, again with raw material routinely tablet manufacturing technology make tablet.
Embodiment 4
Prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 30 Herba Pyrolaes 15
Herba Cistanches 15 Rhizoma Drynariae 20
Herba Epimedii 14 Caulis Spatholobis 10
Semen Raphani 8 Rhizoma Corydalis 8
Radix Cyathulae 6 Radix Clematidis 10
Semen Strychni (processed) 0.6
After said components taken by weighing by weight, the closeer routinely ball production technology of raw material is made close ball.
Embodiment 5
Prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 25 Herba Pyrolaes 18
Herba Cistanches 13 Rhizoma Drynariae 15
Herba Epimedii 12 Caulis Spatholobis 30
Semen Raphani 12 Rhizoma Corydalis 9
Radix Cyathulae 7 Radix Clematidis 8
Semen Strychni (processed) 0.5
After said components taken by weighing by weight, again with raw material routinely capsule manufacture technology make capsule.
Embodiment 6
Prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 10 Herba Pyrolaes 12
Herba Cistanches 17 Rhizoma Drynariae 18
Herba Epimedii 11 Caulis Spatholobis 23
Semen Raphani 7 Rhizoma Corydalis 6
Radix Cyathulae 9 Radix Clematidis 6
Semen Strychni (processed) 0.6
After said components taken by weighing by weight, again with raw material routinely oral liquid process make oral liquid.
Claims (1)
1. compound recipe hyperosteogeny Chinese medicine preparation is characterized in that its prescription and each ingredients weight parts ratio are as follows:
Radix Rehmanniae Preparata 10-30 Herba Pyrolae 5-20
Herba Cistanches 10-20 Rhizoma Drynariae 4-20
Herba Epimedii 10-15 Caulis Spatholobi 10-30
Semen Raphani 5-15 Rhizoma Corydalis 3-10
Radix Cyathulae 4.5-9 Radix Clematidis 5-10
Semen Strychni (processed) 0.3-0.6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00110131 CN1101202C (en) | 2000-02-22 | 2000-02-22 | Compound Chinese medicine preparation for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00110131 CN1101202C (en) | 2000-02-22 | 2000-02-22 | Compound Chinese medicine preparation for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1267526A CN1267526A (en) | 2000-09-27 |
| CN1101202C true CN1101202C (en) | 2003-02-12 |
Family
ID=4580146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00110131 Expired - Fee Related CN1101202C (en) | 2000-02-22 | 2000-02-22 | Compound Chinese medicine preparation for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1101202C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1325681A1 (en) * | 2001-12-11 | 2003-07-09 | Société des Produits Nestlé S.A. | Composition for promotion of bone growth and maintenance of bone health |
| CN103655959A (en) * | 2013-11-21 | 2014-03-26 | 黄萍 | Externally applied traditional Chinese medicine for treating calcaneodynia |
| CN104474209A (en) * | 2014-12-02 | 2015-04-01 | 青岛祥翔生物医药科技有限公司 | Traditional Chinese medicine for treating qi-deficiency and blood-deficiency type heel pain |
| CN108478686A (en) * | 2018-06-20 | 2018-09-04 | 公安县中医医院 | A kind of Qiangjin Zhuanggu capsule and its preparation method |
-
2000
- 2000-02-22 CN CN 00110131 patent/CN1101202C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1267526A (en) | 2000-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1286474C (en) | Medicine for treating bone wound | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1745801A (en) | Ointment for treating spur | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1101202C (en) | Compound Chinese medicine preparation for treating hyperosteogeny | |
| CN1406594A (en) | Oral Chinese medicine for osteoarthritis | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1294974C (en) | Plaster for treating rheumatoid, fracture, sprain and arthritis and preparation method thereof | |
| CN1284580C (en) | Bone Activating stasis transforming capsule | |
| CN1310014A (en) | Lumbago treating Chinese medicine | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN101979036A (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN1136864C (en) | Chinese medicine for treating mastoproliferation | |
| CN1861155A (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
| CN1241626C (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis | |
| CN1112191C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process | |
| CN1092971C (en) | Chinese medicine for treating rheumatism | |
| CN1682811A (en) | Ridge and bone strengthening pill for treating ankylosing spondylitis | |
| CN103656545A (en) | Chinese patent medicine granule for treating arthritis | |
| CN1279958A (en) | Medicine for curing osteomyelitis and its preparing method | |
| CN1387877A (en) | Tonic wine for resisting rheumatism and rhematoid diseases | |
| CN1101201C (en) | Chinese medicine for making lumbus stronger and consolidating vital energy of kidney | |
| CN1127978C (en) | Hyperosteogeny treating medicine | |
| CN1267139C (en) | Medicinal ointment for bone injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030212 Termination date: 20130222 |